Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α
Mitotane is the cornerstone of medical treatment of adrenocortical carcinoma. Estrogenic-like side effects frequently occur in patients, and previous studies explored the chemical nature of the interaction between estrogen receptor-α (ER-α) and toxic compounds, including the DDD derivatives. We used...
Huvudupphovsmän: | , , , , , , , , , |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
MDPI AG
2021-06-01
|
Serie: | Biomedicines |
Ämnen: | |
Länkar: | https://www.mdpi.com/2227-9059/9/6/681 |